949007-44-7

Upstream product

• 990-91-0 dibenzyl [[bis(benzyloxy)phosphoryl]oxy]phosphonate 
• 76375-60-5 (3R,4R,5R,6R)-3-acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate 
• 41355-94-6 benzyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-galactopyranoside 
• 41355-95-7 benzyl 2-acetamido-2-deoxy-β-D-galactopyranoside 
• 868744-51-8 benzyl 2-acetamido-3,6-di-O-benzoyl-2-deoxy-β-D-galactopyranoside 
• 946495-23-4 allyl 2-acetamido-3,6-di-O-benzoyl-2,4-dideoxy-4-fluoro-α-D-glucopyranoside 

Relevant academic research and scientific papers

Chemoenzymatic Synthesis of 4-Fluoro-N-Acetylhexosamine Uridine Diphosphate Donors: Chain Terminators in Glycosaminoglycan Synthesis

Unnatural uridine diphosphate (UDP)-sugar donors, UDP-4-deoxy-4-fluoro-N-acetylglucosamine (4FGlcNAc) and UDP-4-deoxy-4-fluoro-N-acetylgalactosamine (4FGalNAc), were prepared using both chemical and chemoenzymatic syntheses relying on N-acetylglucosamine-

Synthesis of UDP-GlcNAc derivatives modified at OH-4 as potential chain-terminators of chitin biosynthesis

A series of UDP-GlcNAc derivatives and precursors that have been modified at the 4-position were synthesised from N-acetyl glucosamine as potential chain terminators of chitin biosynthesis. None of the UDP-derivatives or the precursors tested displayed an

OLIGOSACCHARIDE BIOSYNTHESIS INHIBITORS

This invention provides a method for inhibiting oligosaccharide biosynthesis in vivo and in vitro comprising the steps of administering at least one monosaccharide derivative, wherein the hydroxyl group which is the glycosyl acceptor (i.e. the active hydr